IL-23 p19 Knockout Mice Exhibit Minimal Defects in Responses to Primary and Secondary Infection with Francisella tularensis LVS

• Sherry L. Kurtz,

  Affiliation Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, United States of America

  ⨯
• Alicia Y. Chou,

  Current address: Reagan-Udall Foundation for the Food and Drug Administration, Washington DC, United States of America

  Affiliation Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, United States of America

  ⨯
• Klara Kubelkova,

  Current address: University of Defence, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic

  Affiliation Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, United States of America

  ⨯
• Daniel J. Cua,

  Affiliation Pathway Biology, Merck Research Laboratories, Palo Alto, CA, United States of America

  ⨯
• Karen L. Elkins

  * E-mail: Karen.elkins@fda.hhs.gov

  Affiliation Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, United States of America

  ⨯